ASX
Anagenics Limited
AN1:ASX•Consumer Defensive
Sensitive ASX Announcement
CELLMID TO COMMENCE SELLING OF EVOLIS INTO CHINESE MARKET
Published: 02/05/18, 10:21am (AEST)•3 pages